Clinical impact and diagnostic accuracy of 2-[18F]-fluoro-2-deoxy-d-glucose positron-emission tomography/computed tomography (PET/CT) brain imaging in patients with cognitive impairment: a tertiary centre experience in the UK

•Dementia is a clinical problem of worldwide concern. •Timely clinical diagnosis of dementia can be challenging in some patients. •FDG PET/CT is an important diagnostic tool in unexplained cognitive impairment. •FDG PET/CT had an impact on clinical management in >80% of these patients. •FDG PET/CT had an accuracy of 94% for the diagnosis of Alzheimer's Disease. Aim To evaluate the clinical impact of combined 2-[18F]-fluoro-2-deoxy-d-glucose...